Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation.

Cell reports | 2018

Arginine methylation is a post-translational modification that plays pivotal roles in signal transduction and gene transcription during cell fate determination. We found protein methyltransferase 6 (PRMT6) to be frequently downregulated in hepatocellular carcinoma (HCC) and its expression to negatively correlate with aggressive cancer features in HCC patients. Silencing of PRMT6 promoted the tumor-initiating, metastasis, and therapy resistance potential of HCC cell lines and patient-derived organoids. Consistently, loss of PRMT6 expression aggravated liver tumorigenesis in a chemical-induced HCC PRMT6 knockout (PRMT6-/-) mouse model. Integrated transcriptome and protein-protein interaction studies revealed an enrichment of genes implicated in RAS signaling and showed that PRMT6 interacted with CRAF on arginine 100, which decreased its RAS binding potential and altered its downstream MEK/ERK signaling. Our work describes a critical repressive function for PRMT6 in maintenance of HCC cells by regulating RAS binding and MEK/ERK signaling via methylation of CRAF on arginine 100.

Pubmed ID: 30332648 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Addgene (tool)

RRID:SCR_002037

Non-profit plasmid repository dedicated to helping scientists around the world share high-quality plasmids. Facilitates archiving and distributing DNA-based research reagents and associated data to scientists worldwide. Repository contains over 65,000 plasmids, including special collections on CRISPR, fluorescent proteins, and ready-to-use viral preparations. There is no cost for scientists to deposit plasmids, which saves time and money associated with shipping plasmids themselves. All plasmids are fully sequenced for validation and sequencing data is openly available. We handle the appropriate Material Transfer Agreements (MTA) with institutions, facilitating open exchange and offering intellectual property and liability protection for depositing scientists. Furthermore, we curate free educational resources for the scientific community including a blog, eBooks, video protocols, and detailed molecular biology resources.

View all literature mentions

New England Biolabs (tool)

RRID:SCR_013517

An Antibody supplier

View all literature mentions

Anti-Raf-1 (antibody)

RRID:AB_310580

This polyclonal targets Raf-1

View all literature mentions

normal rabbit IgG (antibody)

RRID:AB_737197

This unknown targets normal rabbit IgG

View all literature mentions

PRMT6 Antibody (antibody)

RRID:AB_661910

This unknown targets PRMT6

View all literature mentions

Histone H3 antibody [mAbcam 24834] (antibody)

RRID:AB_470335

This monoclonal targets Histone H3 antibody [mAbcam 24834]

View all literature mentions

MEK1/2 Antibody (antibody)

RRID:AB_823567

This polyclonal targets MEK1/2

View all literature mentions

Phospho-MEK1/2 (Ser217/221) (41G9) Rabbit mAb (antibody)

RRID:AB_2138017

This monoclonal targets Phospho-MEK1/2 (Ser217/221)

View all literature mentions

p44/42 MAPK (Erk1/2) Antibody (antibody)

RRID:AB_330744

This polyclonal targets p44/42 MAPK (Erk1/2)

View all literature mentions

B-Raf (55C6) Rabbit mAb (antibody)

RRID:AB_2259354

This monoclonal targets B-Raf

View all literature mentions

A-Raf Antibody (antibody)

RRID:AB_330813

This polyclonal targets A-Raf

View all literature mentions

c-Raf (D5X6R) (antibody)

RRID:AB_2728706

This monoclonal targets c-Raf

View all literature mentions

Phospho-c-Raf (Ser338) (56A6) Rabbit mAb (antibody)

RRID:AB_2067317

This monoclonal targets c-Raf, phospho (Ser338)

View all literature mentions

NANOG-human (antibody)

RRID:AB_2150399

This polyclonal targets NANOG

View all literature mentions

Anti-SOX2 antibody (antibody)

RRID:AB_2341193

This polyclonal targets sox2

View all literature mentions

PRMT6 antibody (antibody)

RRID:AB_2284473

This polyclonal targets Prmt6

View all literature mentions

CD90-FITC, human (antibody)

RRID:AB_2660947

This monoclonal targets CD90

View all literature mentions

CD133/2 (AC141)-PE, human (antibody)

RRID:AB_244348

This monoclonal targets CD133/2 (AC141)

View all literature mentions